Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05958641
Other study ID # 202310893
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 17, 2023
Est. completion date November 30, 2023

Study information

Verified date July 2023
Source Sun Yat-sen University
Contact Wei Xia, PhD
Phone 18823359471
Email xiaw23@mail.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model of the New Psychoactive Substances (NPS) using for adolescents aged 14-35 years old. This study intends to obtain the data related to the behavioral expression of addiction susceptibility genes, adverse childhood experience, cognition, resistance and the use of NPS in adolescents by questionnaire survey (sample size: 200), and then use logistic regression and machine learning to construct an early warning model.


Description:

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model on the use of the New Psychoactive Substances using for adolescents aged 14-35 years old. This study intends to conduct a questionnaire survey (sample size 200) to obtain data related to the behavioral expression of addiction susceptibility genes, childhood adversity experience, cognition, resistance and the use of NPS in adolescents from different regions and different populations. Through data analysis, this study aims to get the weight of different risk factors on NPS use, and then use logistic regression and machine learning to construct an early warning model, so as to screen out high-risk groups. At the same time, the expert group was consulted to establish a risk early warning system to provide a basis for intervention.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date November 30, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Years to 35 Years
Eligibility Inclusion Criteria: - Adolescents aged 14-35 (including 14,35 years old) - Agree to participate in the studies Exclusion Criteria: - Be diagnosed with psychological or mental illness - People that are unconscious, emotionally unstable, or unable to communicate normally - Patients with severe diseases

Study Design


Intervention

Other:
Questionnaires
Participants will be asked to complete the questionnaire including general demographic information, the cognition, resistance and use of NPS as well as the behavioral expression of addiction susceptibility genes and adverse childhood experience.

Locations

Country Name City State
China Sun Yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Wei XIA, PhD

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the cognition of NPS knowledge questionnaire of drug types and risk awareness of drug use will be investigated to know the degree of cognition to NPS Baseline
Primary the resistance of NPS the drug refusal self-efficacy scale and the drug use permissive attitude will be used to measure the the resistance of NPS Baseline
Primary the use of NPS there will be some questions to investigate the drug use conditions Baseline
Primary Adverse Childhood Experience the Chinese version of Adverse Childhood Experience Scale with 10 items will be used to measure the adverse childhood experience Baseline
Primary hedonic hunger the Power of Food Scale with 15 items will be used to measure hedonic hunger Baseline
Primary sensation seeking personality the Brief Sensation Seeking Scale for Chinese with 8 items will be used to measure sensation seeking personality Baseline
Primary prosocial behavior the Prosocial Tendencies Measure with 26 items will be used to measure prosocial behavior Baseline
Primary externalizing behavior 17 items of aggressive behavior and 15 items of rule-breaking behavior from the Chinese Version of Achenbach Youth Self-Report-2001 Version will be used to measure adolescents' degree of externalizing behavior Baseline
Primary sleep quality the Pittsburgh Sleep Quality Index with 9 items will be used to measure adolescents' sleep quality Baseline
See also
  Status Clinical Trial Phase
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT02192931 - A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users Phase 4
Completed NCT02939352 - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues Early Phase 1
Completed NCT02437123 - The Cedar Project: Impact of mHealth for HIV Prevention Among Young Indigenous People Who Use Illicit Drugs N/A
Completed NCT01685073 - The Role of Sleep in the Treatment of Cannabis Use Disorders Phase 2/Phase 3
Completed NCT01591239 - Home-Based Program to Help Parents of Drug Abusing Adolescents N/A
Completed NCT00317460 - Buprenorphine and Integrated HIV Care Phase 4
Completed NCT03678051 - CBT4CBT for Women in Residential Treatment for Substance Use Disorders N/A
Completed NCT04105621 - Westlake Personalized Nutrition and Health Cohort for Drug Addicts
Withdrawn NCT05440721 - Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification N/A
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT00496990 - Treating the Partners of Drug Using Pregnant Women: Stage II Phase 2/Phase 3
Completed NCT00244699 - Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth N/A
Completed NCT00390559 - Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3 N/A
Completed NCT03402672 - AWAITS: A Web-based E-health Application for Active Illicit Opioid Users N/A
Completed NCT03411265 - RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing N/A
Completed NCT01003496 - Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial Phase 3
Completed NCT02091167 - Bilateral Prefrontal Modulation in Crack-cocaine Addiction Phase 2
Completed NCT02091284 - Bilateral Prefrontal Modulation in Alcoholism N/A